Current stock research snapshot · 8/6/26 20 days old

CERTCertara Inc.

POOL
Investment conviction●●○○○2 of 5 · current snapshot
Research target$16Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 8/6/26
Market cap$1.17BSnapshot value · 8/6/26

What changed

See all CERT changes ↗

Target
$16.12 $16

Biosimulation software and services for clinical trial design optimization — digital infrastructure picks-and-shovels for pharma R&D. $355M rev, $1.7B cap.

NVIDIA BioNeMo Agent Toolkit integration announced Jul 2026 (AI-driven biosimulation automation); Q2 2026 earnings early Aug (services stabilization, AI monetization progress); Bio Venture Catalyst program launch at BIO 2026 for emerging biotechs; Certara IQ QSP platform expansion

needs primary source validation

needs primary source validation

Snapshot · 8/6/26

🟡 Mixed · 13F 16+/7-×0.5 · short↑0.28

Snapshot · 8/6/26